Phase 2 trial shows sorfequiline with pretomanid and linezolid may enhance TB treatment efficacy and safety for drug-sensitive patients.
Every year on 16 November, the world observes International Tolerance Day, established by UNESCO and the United Nations in ...
A global health initiative that works to fight AIDS, tuberculosis and malaria raised $11.34 billion at an event in ...
A slew of new studies and reports suggest that new molecular approaches may soon help reduce the global burden of tuberculosis.
Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...
News-Medical.Net on MSN
New clinical trial shows promise for shorter TB treatment
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
Researchers in the TB Alliance informed the Union Conference on Lung Health in Copenhagen that Sorbequiline, a new antibiotic ...
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback